MidAmerica Division, Inc. c/o Menorah Medical Center — Overland Park, Kansas

MidAmerica Division, Inc. c/o Menorah Medical Center is a clinical research site located in Overland Park, Kansas, United States 66209.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

MidAmerica Division, Inc. c/o Menorah Medical Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Non-small Cell Lung Cancer, Diffuse Large B-cell Lymphoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Division, Inc. c/o Menorah Medical Center?

MidAmerica Division, Inc. c/o Menorah Medical Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Division, Inc. c/o Menorah Medical Center conducted?

MidAmerica Division, Inc. c/o Menorah Medical Center has 3 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Non-small Cell Lung Cancer, Diffuse Large B-cell Lymphoma.

Is MidAmerica Division, Inc. c/o Menorah Medical Center accredited by Crixeo Health?

MidAmerica Division, Inc. c/o Menorah Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Division, Inc. c/o Menorah Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.